Schedule at a Glance

Note: All session times are listed in Eastern Daylight Time.

*This session is not available for AMA PRA Category I Credit(s)™. Please refer to the CME page for more information. 

Saturday, October 16, 2021
3:30 PM – 4:30 PM
3:30 PM – 7:00 PM
Poster Viewing*
E-poster presentations are available for viewing throughout the duration of the meeting.
5:00 PM – 7:00 PM
Opening Symposium: Insights Into the Genetic Underpinning and Treatment of Epilepsy
  • Aberrant Inclusion of Poison Exons Leads to Premature Truncation of Ion Channels in Epilepsy
  • Dancing to a Different Tune: TANGO Gives Hope for Dravet Syndrome
  • Genetic Basis of Epilepsy
  • Oncogene-Driven Epileptogenesis
  • Stereo-electroencephalographic Language and Memory Mapping: “Electric Wada” and High Gamma Activity
Sunday, October 17, 2021
10:00 AM – 8:45 PM
Poster Viewing*
E-poster presentations are available for viewing throughout the duration of the meeting.
10:00 AM – 12:00 PM
Presidential Symposium: COVID-19 Pandemic: Population Impact and Responses, and Neurological Complications
  • How COVID-19 Has Emphasized Health Care Disparities
  • Long-term Effects of Covid-19: Characterization of Clinical, Imaging and Laboratory Features
  • Neurobiology of COVID-19
  • Neurological Consequences of COVID-19: Acute and Chronic
  • Operation Warp Speed: How COVID Vaccines Were Developed in Record Time
12:15 PM – 1:15 PM
AUPN Course 1: Equity, Diversity & Inclusion: What Does It Take to Make Real Progress and How Do You Improve the Pipeline?
Professional Development Course: ANA-AUPN Chair Career Level
  • Pre-Faculty Development: A Critical Factor in Diversifying Academic Medicine
  • Putting Equity, Diversity, and Inclusion into Practice
  • Tips for Hiring a Diverse Workforce - Lessons Learned from...Alabama?
Course 1: Becoming a Successful Medical Director
Professional Development Course: Early to Mid-Career Level
  • Developing a Basic Understanding of Financial Aspects of an Academic Medical Practice
  • Negotiating for Additional Clinical and Research Resources
  • The Role of Medical Directors in Academic Settings
Course 1: Landing Your Fellowship and First Faculty Position
Professional Development Course: Early Career Level (Student, Resident, Trainee, Postdoc Fellow)
  • Approaching Negotiation and Contracts
  • Finding Good Fits in Fellowship & Faculty Positions
1:45 PM – 2:45 PM
Emerging Scholar Lecture Series 1
  • Cortico-hippocampal Circuit Dysfunction in a Mouse Model of Dravet Syndrome
  • Imaging Prodromal Neuromelanin and Iron Pathology in REM Sleep Behavior Disorder
  • Real-Time Longitudinal Tracking of Neuronal Death and Seizures After Perinatal Oxygen-Glucose Deprivation
  • Sleep Disruption in a Mouse Model of Medial Temporal Lobe Epilepsy
3:15 PM – 5:15 PM
Advances in Amyotrophic Lateral Sclerosis*
  • Antisense Oligonucleotide Therapy for SOD1 ALS
  • Mapping of Critical Events in ALS Progression
  • Recent Advances in ALS
  • Regulation of TDP-43 Nucleocytoplasmic Shuttling and Therapeutic Targeting
  • Unraveling the Genomics of ALS
5:30 PM – 6:30 PM
Poster Tour: ALS*
  • CK1ε-Dependent TDP-43 Phosphorylation in ALS
  • Dynamic Network Stability Analysis For Prioritizing Experimental Combination Therapies For Amyotrophic Lateral Sclerosis
  • Neurotoxic Properties of Human Endogenous Retrovirus-k Envelope Protein and Detection in Cerebrospinal Fluid of Patients with Am
  • New Candidate for Sporadic ALS Therapy. Targeting CHMP7 with ASO: Preventing Nuclear Pore Injury
  • Sex and Age Impact The Role of The Immune System in Amyotrophic Lateral Sclerosis
  • The Gut Microbiome: Modulator of Environmental Insults in Amyotrophic Lateral Sclerosis
Poster Tour: Autoimmune 1*
  • Clinical Outcomes Following Status Epilepticus in Anti-nmdar Encephalitis
  • High Frequency of Asymptomatic Optic Nerve Enhancement in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
  • Investigations in Ca<sup>2+</sup> Signaling in Anti-NMDAR Encephalitis
  • The Use of Routine Laboratory Parameters for Prediction of an Infectious or Autoimmune Etiology in Encephalitis
Poster Tour: Cerebrovascular 1*
  • Differences in Peripheral Leukocyte Subtypes Between Slow and Fast Progressors of Infarct Growth in Anterior Circulation Large V
  • Estimated Hypoperfusion Using Flair Predicts Presence And Severity Of Hemispatial Neglect
  • Extrastriate Visual Cortex Damage and Temporo-Parietal Disconnection in Anton Syndrome
  • Genetic and Electrophysiological Biomarkers of Neuroplasticity Predict Post-Stroke Language Recovery
  • Intraventricular Tissue Plasminogen Activator Use and Reduction of Parenchymal Hematoma Volume in the Clear III Trial
  • Left Atrial Strain and Atrial Cardiopathy in Embolic Strokes of Undetermined Source (ESUS)
Poster Tour: COVID-19*
  • Analysis of COVID-19 Brain Autopsies Reveals That Neuroinflammation is Not Caused by Direct SARS-CoV-2 Infection of the CNS
  • Assessment of the Efficacy of a Virtual Neurology Elective for Medical Students Developed During COVID-19
  • Encephalopathy in Patients with COVID-19 Infection
  • Ncephalopathy, Epileptiform Activity, and Seizures in Patients with Covid-19
  • Response to COVID-19 mRNA Vaccination in Patients with Multiple Sclerosis on Anti-CD20 Disease Modifying Therapies
  • The Mas Receptor Agonist TXA127 Blocks Neurovascular Inflammation Associated with Sars-CoV-2 Infection
Poster Tour: Dementia 1*
  • Baseline Multimodal Imaging to Predict Longitudinal Decline in Atypical Alzheimer’s Disease
  • Central Precuneus Lesions Are Associated with Impaired Executive Function
  • Inhibition of Hallucinations Through Electrical Stimulation of The Cerebellum
  • Introducing DBM-21, a Novel and Potent Imaging Biomarker for Accurate and Non-invasive Early Detection of Alzheimer’s Disease
  • Peripheral Inflammation and Depressed Mood Independently Predict Neurocognitive Worsening Over 12 years
  • SV2C is Required for Nicotine-Mediated Rescue of α-Synuclein Toxicity
Poster Tour: Tauopathy*
  • Assessing Symptom Severity of Primary Progressive Aphasia in Research Cohorts
  • Behavioral Disturbances in Progressive Apraxia of Speech and Agrammatic Aphasia
  • Investigating the Utility of Common Linguistic Tasks in Distinguishing PPA Subtypes
  • Neuroimaging Associations with 4R Tauopathies in Progressive Apraxia of Speech
  • Patterns of Cortical Tau Pathology in LBD and PSP: A Multi-center Digital Histology Study
  • Regional Atrophy Predicts Naming Decline in Primary Progressive Aphasia: A Comparison of Cross-sectional and Longitudinal Analyses
6:45 PM – 7:45 PM
Poster Tour: Autoimmune 2*
  • Challenging Diagnosis of Stroke in Young: A Case Report Reflecting Delayed Diagnosis of Takayasu Arteritis and Use of Ultrasound
  • Genomic & Transcriptomic-wide Analysis Identifies Novel Genetic Risk Loci and Prioritization of Therapies for Myasthenia Gravis
  • Hematologic Dysfunction in Aicardi Goutières Syndrome
  • Intraventricular Tissue Plasminogen Activator Use and Reduction of Parenchymal Hematoma Volume in the Clear III Trial
  • LGI4 is a Novel Autoantigen for Nodopathy/Paranodopathy Type Chronic Inflammatory Demyelinating Polyneuropathy
  • Reverse Transcriptase Inhibition as a Novel Therapeutic Approach for ADAR1-Related Aicardi Goutières Syndrome
Poster Tour: Cerebrovascular 2*
  • Adding MRI After CT is Not Associated with Improved Ischemic Stroke Outcomes at Discharge
  • Duration of Heightened Ischemic Stroke Risk Following Hospitalization for Acute Systolic Heart Failure
  • Early Deterioration, Hematoma Expansion, and Outcomes After Lobar Intracerebral Hemorrhage in the FAST Trial
  • Elevated Initial Troponin I Levels in Patients with Spontaneous Intracerebral Hemorrhage Predict Poor Functional Outcome
  • Reducing Readmission Rates By Improving Transitions Of Care For Stroke Patients In The Pre-Covid And Covid Eras
  • Stroke Severity and Post-acute Care Discharge Setting Interact to Predict Mortality After Stroke
Poster Tour: Dementia 2*
  • A Machine Learning Approach to Analyze the Efficacy of Standard Clinic Metrics for Predicting Alzheimer Progression
  • Abeta-accelerated Neurodegeneration Caused by Alzheimer’s-associated ACE Variant R1279Q is Rescued by Angiotensin System Inhibit
  • Structural and Molecular Determinants of Repeat RNA Toxicity in Non-amyloid Dementias
  • Towards Universal Deep Learning Artificial Intelligence for Alzheimer’s Disease Magnetic Resonance Imaging
  • Tractography Analysis of Supplementary Motor Area White Matter Tracts in Progressive Apraxia of Speech and Agrammatic Aphasia
Poster Tour: Epilepsy 1*
  • Association of COVID-19 Infections with New-onset and Breakthrough Epileptic Seizures
  • Cortico-Cortical Evoked Potential Amplitudes Cannot Be Interpreted Without Correcting for Distance
  • Depression and Anxiety in Adult Persons with Epilepsy and Their Caregivers
  • Long-term Efficacy and Safety of Adjunctive Perampanel in Elderly Patients (aged ≥60 Years) with Focal-onset Seizures (FOS)
  • Non-cell Autonomous Hyperexcitability Underlies Focal Epileptogenesis Mediated by Low-level Brain Somatic Mutations in Mtor
  • Patient Reported Outcomes of Anxiety and Depression in Epilepsy: Usual Care Outcomes in a Pilot RCT of Remote Outcome Assessment
Poster Tour: Headache*
  • Efferent Projections of CGRP/Calca-Expressing Parabrachial Neurons in Mice
  • External Trigeminal Nerve Stimulation (e-TNS) Demonstrated Efficacy in the Acute Treatment of Migraine: Results from TEAM
  • Mindfulness-based Stress Reduction (MBSR) vs. HA Education: an RCT Showing Mindfulness Targets Total Migraine Burden
  • Noninvasive Combined Occipital / Trigeminal Nerve Stimulation - Established Efficacy, Safety & Tolerability
  • Sensory Predictors of Post-Traumatic Headache Related Disability
  • Total Pain Burden in Patients with Treatment-resistant Migraine: Effects of Galcanezumab in the CONQUER Phase 3b Trial
Poster Tour: Neuropathy*
  • A Pilot Study on Hand Palmar and Digital Nerve Ultrasound in Peripheral Nerve Diseases
  • NADPH Oxidase 5: A New Player in Peripheral Neuropathy
  • Peripheral Neuropathic Changes in Prurigo Nodularis
7:45 PM – 8:45 PM
Monday, October 18, 2021
10:00 AM – 11:00 AM
AUPN Course 2: Social Media and Web Presence: How Do You Make Your Internet Presence Effective, and How Do You Handle Social Media "Surprises"?
Professional Development Course: ANA-AUPN Chair Career Level
  • Overview of Social Media for Chairs
  • Social Media from the Trainee Perspective
  • Stepping Carefully in the Twitter Verse
  • Using Social Media for Neurology Education
Course 2: View From the NINDS, NIA, NICHD, DOD and the VA
Professional Development Course: Early Career Level (Student, Resident, Trainee, Postdoc Fellow) & Early to Mid-Career Level
  • DOD Funding Opportunities for Neuroscience and Neurology Research
  • Meet the NINDS
  • NIA Alzheimer's Disease Funding Update
  • Opportunities in VA Research
  • Research Opportunities From the NICHD
10:00 AM – 8:45 PM
Poster Viewing*
E-poster presentations are available for viewing throughout the duration of the meeting.
11:15 AM – 12:45 PM
Curing Coma – Science and Decision-Making for Recovery of Impaired Consciousness
  • Biomarkers from Electrophysiology and Imaging to Identify Capacity for Coma Recovery
  • Developmental Aspects Relevant to Recovery From Coma in Children
  • The Science of Decision-Making in the Face of Uncertainty After Coma
  • The World Brain Death Project: Developing International Consensus
  • Therapies for Coma Recovery: Current Treatments and Future Interventions
IDEAS to Action: Leading Diversity Initiatives in Academic Neurology
  • Community Partnerships in Academic Neurology
  • Diversity in Education
  • Inclusive Healthcare: A Triple Tier Academic Approach
Neuropsychiatric Disorders in Adults and Children: Approach to the Diagnosis and Potential for Precision Behavioral Neurology
  • Advances in Neuropsychiatric Genomics
  • Mechanisms of Antibody Mediated Cognitive Impairment
  • Neuropsychiatric Characteristics of Autoimmune Encephalitis in Adults and Children
11:30 AM – 12:30 PM
1:00 PM – 2:00 PM
Emerging Scholar Lecture Series 2
  • Childhood Amyotrophic Lateral Sclerosis Caused by Excess Sphingolipid Synthesis
  • Global Burden of Pain-related Disorders: A Longitudinal Analysis of the Global Burden of Disease Study (1990 - 2019)
  • Monocyte Transcriptomic Analysis of High-risk Carotid Atherosclerosis
  • Neuronal Subtype-specific Vulnerability to Demyelination in DRG Neurons
2:30 PM – 4:30 PM
Derek Denny-Brown Young Neurological Scholar Symposium*
  • Audrey S. Penn Lectureship - Inclusive Healthcare: A Triple Tier Academic Approach
  • Audrey S. Penn Lectureship - Sustainability and Growth: the MGH Youth Neurology Education and Research Program
  • Derek Denny-Brown Young Neurological Scholar - Basic Science - The Striatal Origins of Action Selection and When They Fail
  • Derek Denny-Brown Young Neurological Scholar - Clinical Science - Piloting Individualized Therapies for Orphan Neurogenetic Disease
  • Derek Denny-Brown Young Neurological Scholar - Neuroscience - New Approaches to Alzheimer’s: From Neural Deficits to Neural Stimulation
  • Grass Foundation - ANA Award in Neuroscience - APOE Genotype and Cognitive and Reactive Glia Phenotypes in Alzheimer's Disease
  • Wolfe Neuropathy Research Prize - Insights Into the Pathogenesis of TRPV4 Neuropathy Highlight the Therapeutic Potential Of TRPV4 Ion Channel Inhibition
4:30 PM – 5:15 PM
5:15 PM – 6:15 PM
Poster Tour: Autoimmune 3*
  • Can Clippers be Diagnosed without Pontine Involvement?
  • Functional Prioritization of Multiple Sclerosis-Associated Genetic Variants That Perturb Regulatory Element Activity in T Cells
  • Geographical Variation in Proportion of Musk Antibody Myasthenia Gravis Around the World - A Multicenter Study
  • Headaches and Neurologic Deficits with Cerebrospinal Fluid Lymphocytosis Syndrome Post Sars-cov-2 Infection: A Case Report
  • Interrogation of Extracellular Vesicle miRNA Repertoire in Adult and Pediatric MS
  • Leukocyte Adhesion causes Brain Capillary Obstruction during Neurotoxicity in a Mouse Model of Chimeric Antigen Receptor (CAR) T
  • Mental Health Associations Among People with Multiple Sclerosis During COVID-19
Poster Tour: Cerebrovascular 3*
  • Evaluating the Impact of a New Model of Structured Interprofessional Bedside Rounding (TeaminguUP) on Climate Safety in an Inpatient Stroke Unit
  • Natural Language Processing Model to Extract Acute Abnormalities from Ct Head Reports
  • Sex Differences in Risk Factor Control Among Patients Undergoing Thrombectomy for Acute Ischemic Stroke
  • Stroke as a Cause of Donor Brain Death and Prognostic Implication in Heart Transplantation
  • White Matter Microstructure as a Predictor of Clinical Response to tDCS in Post-Stroke Aphasia
Poster Tour: Dementia 3*
  • Anti-Hypertensive Medication Use is Associated with Decreased Likelihood of Neurodegenerative Pathologies
  • Differentiating the Cognitive Trajectory of TDP-43 vs. Alzheimer's Disease Neuropathology in the Oldest Old
  • Non-Invasive Deep Brain Modulation in Humans via Rhythmic Sensory Stimulation
  • Periventricular White Matter Hyperintensities Are a Potential Noninvasive Imaging Marker for Alzheimer-like Cerebrospinal Fluid
  • Transcriptomic Analyses of Synaptic, Amyloid, and Tau Pathways in A20-Deficient Mice
  • Unsupervised Machine Learning to Identify Separable Clinical Alzheimer’s Disease Sub-Populations
Poster Tour: Epilepsy 2*
  • A Single-center Retrospective Analysis of Occipital Lobe Epilepsy Surgery Outcomes at Mayo Clinic Arizona
  • Failed Acute Stroke Interventions and High Ischemic Burden Increase Post-stroke Epilepsy Risk
  • Looking Beyond Apnea: A Widespread Cortical Repertoire That Modulates the Rate and Depth of Breathing
  • Presurgical Evaluation Initiation Among Medicare Beneficiaries with Refractory Epilepsy
  • Total Daily Dosage of Anti-Epileptic Drugs in Women with Epilepsy with Subsequent Pregnancies
Poster Tour: Movement Disorders 1*
  • Characterizing the Role of Genetic Variants Influencing α-synuclein Seeding Activity Neuropathologically Quantified Human Brains
  • Clusters of Olfactory Performance are Associated with Motor Decline in LRRK2 G2019S Variant Parkinson Disease
  • Investigation and Rescue of Disrupted SNARE-mediated Macroautophagy in Parkinson's Disease
  • Monogenic Hub of the Global Parkinson’s Genetics Program (GP2): The 500 Genomes Pilot Project
  • SV2C is Required for Nicotine-Mediated Rescue of α-Synuclein Toxicity
  • Satisfaction with Interdisciplinary Home Visits Among Individuals with Advanced Parkinson’s Disease and Their Caregivers
Poster Tour: Neuromuscular 1*
  • A Rare Case of Rapidly Progressive Myasthenia Gravis with Coexisting Necrotizing Autoimmune Myopathy
  • Brain Structure and Cognitive Endpoints in Myotonic Dystrophy Type 2
  • Germline and Therapeutic Suppression of Tubulin Alpha 4a Rescues H-abc Leukodystrophy in Mice
  • Leriglitazone Reduces Cerebral Lesions and Improves Biomarkers Related to Axonal Degeneration, Inflammation and Compromised Blood-brain-barrier in Patients with Adrenomyeloneuropathy
  • Muscle Biopsy in an Era of Neurogenetics: A Novel Mutation Leading to Becker Muscular Dystrophy
  • Opioid Initiation for Common Neurologic Diagnoses: A US Population-based Medicare Study
6:30 PM – 7:30 PM
Poster Tour: Dementia 4*
  • Machine Learning Classification of Diagnostic Proteomics for Alzheimer Disease
  • Pathophysiological Changes In Soluble Amyloid Precursor Protein; Turnover In Alzheimer's Disease
  • Quantitative and Qualitative EEG Differences Between Dementia with Lewy Bodies and Alzheimer's Disease
  • Systemic Inflammation Elicits Distinct Brain Immune Signaling Dynamics in Female and Male Mice with AD Pathology
  • Written Language Impairments in Subgroups of Mild Cognitive Impairment
Poster Tour: Epilepsy 3*
  • Epilepsy Stigma in the Republic of Guinea and its Demographic, Social, and Clinical Associations: A Cross-Sectional Analysis
  • Natural Language Processing To Assess Seizure Frequency
  • Occurrence of Seizure Worsening and Clinical Toxicity During Postpartum Lamotrigine Taper in Women with Epilepsy
  • Pv+ Interneurons Are Non-cell Autonomously Dysregulated in Depdc5-associated Epilepsies
  • Trio Exome Sequencing with In-Depth Phenotyping in Pediatric Epilepsy: A Prospective, Single-Centered Cohort Study with Return
Poster Tour: Movement Disorders 2*
  • A Proposed Electronic Health Record Algorithm for Parkinson's Disease Case Identification
  • Characterization of a Mouse Model of Pde10a-Related Autosomal-Dominant Movement Disorder
  • DYT-TOR1A Subcellular Proteomics Reveals Selective Vulnerability of the Nuclear Proteome to Cell Stress
  • Effect of Hydrogen Sulfide on Alpha-synuclein Aggregation
  • Efficacy of ASN51, an Orally Bioavailable Small-Molecule O-GlcNAcase Inhibitor, in Models of Parkinson's Disease and Epilepsy
  • Heterozygous PRKN Mutations are Common but do not Increase the Risk of Parkinson’s Disease
  • Stabilization of Overall Quality of Life via Interdisciplinary Home Visits Among Individuals with Advanced Parkinson's Disease
Poster Tour: Neuromuscular 2*
  • Defects in Mitochondria-lysosome Contact Site Dynamics in Charcot-Marie-Tooth Type 2 Disease
  • Loss of TDP-43 Function and Rimmed Vacuoles Persist After T Cell Depletion in a Xenograft Model of Inclusion Body Myositis
  • Mitochondrial Replisome Protein Changes in Aging Mice
  • Monounsaturated Fatty Acids Rescue Peripheral Nerve Function and Increase Very-long Chain Sphingolipids in the Sciatic Nerve of Murine Models of Prediabetes
Poster Tour: Sleep*
  • Daytime Sleepiness in Parkinson’s Disease: Subjective and Objective Measures
  • Effects of Lower-Sodium Oxybate on Functioning and Work Productivity in Participants with Idiopathic Hypersomnia
  • Global and Local Sleep Changes in Brain Oscillations After Stroke
  • New Insight into REM Sleep Behavior Disorder Circuits in Living Humans
  • Sleep Disturbances in Two Progressive Supranuclear Palsy Variants
Poster Tour: Traumatic Brain Injury*
  • AMA Guides® To The Evaluation Of Permanent Impairment : Achieving Equitable Impairment Ratings Through The Most Current Medicine
  • Associations of Pre-injury Vascular Risk Factors with Traumatic Brain Injury Outcomes: A TRACK-TBI Study
  • Does Concomitant Traumatic Brain Injury Adversely Affect Survival, and Neurological and Functional Recovery After Acute Traumatic Spinal Cord Injury?
  • Epigenetic Regulation of Abcc8 and Trpm4 is Associated with Intracranial Hypertension and Outcome After Severe TBI
  • Mild Behavioral Impairment Domains Are Associated with Traumatic Brain Injury in All-cause Dementia
  • Poor Cognitive Outcome One Year After Mild Traumatic Brain Injury: Results from the TRACK-TBI Study
  • Resilience of Arousal Mechanisms in Traumatic Coma
7:45 PM – 8:45 PM
Tuesday, October 19, 2021
8:30 AM – 9:30 AM
New Hope for Early-Stage Alzheimer's Disease: Can We Modify the Disease Pathway by Targeting Amyloid-β?**
Sponsored By: Answers in CME (This activity is supported by an educational grant from Biogen)
8:30 AM – 5:30 PM
Poster Viewing*
E-poster presentations are available for viewing throughout the duration of the meeting.
10:00 AM – 11:00 AM
AUPN Course 3: Supply and Demand in Neurology Subspecialties: How Can You Match the Trajectories of Trainees to the Needs of the Present and Future?
Professional Development Course: ANA-AUPN Chair Career Level
  • Scenario 1 - The Medical Student (MD and MD, PhD, Physician Scientist)
  • Scenario 2: The Non-Committed Resident
  • Scenario 3: Returning Resident with Location Preferences (General Neurology)
Course 3: Physician-Scientist Careers and Collaborations With Industry
Professional Development Course: Early Career Level (Student, Resident, Trainee, Postdoc Fellow) & Early to Mid-Career Level
  • Academia-Industry Collaborations in Clinical Trial Readiness
  • Physician-Scientists in Industry: An Inside View
  • Scientist Careers and Collaborations with Industry
11:15 AM – 12:15 PM
A Good Recovery? Under-Recognized Deficits Significantly Impact Functional Outcomes Post-Stroke
  • Cognitive Disruption After Minor Stroke Is Due to Network Disruption
  • Mindfulness Based Stress Reduction May Improve Post-Stroke Cognition
  • The Impact of Hemispatial Neglect on Post-Stroke Rehabilitation
  • The Role of TMS to Treat Post-Stroke Cognitive Deficits
Artificial Intelligence Applications in the Clinical Assessment of Alzheimer’s Disease
  • AI Applications in Imaging for Alzheimer’s Disease
  • Artificial Intelligence Approaches for Discovery in Alzheimer’s Disease Biobanks
  • The Benefits of AI in the Alzheimer’s Clinic: A Clinician’s Perspective
Deconvoluting FDA Decisions Regarding Neurological Diseases
  • Crossing the Finish Line: Marathons and SPRINTS
  • Moving Medical Devices to Patients in the US
  • Serving on a FDA Advisory Committee: A Neurologist’s Perspective
12:30 PM – 1:30 PM
Emerging Scholar Lecture Series 3
  • Autophagy & Neurons: Targeting Protein Quality Control for Modifying Proteostasis and Discovering Therapeutic Targets for Neurodegenerative Diseases
  • Complexes of Soluble α-synuclein and Amyloid-ß with Their Cognate Antibodies Activate the NLRP3 Inflammasome in hiPSC-Derived Microglia
  • Gamma Frequency Sensory Stimulation in Probable Mild Alzheimer's Dementia Patients: Results of a Preliminary Clinical Trial
  • Pulse-chase Proteomics of the App Knock-in Mouse Models of Alzheimer’s Disease Reveals Synaptic Dysfunction Originates in Presynaptic Terminals
2:00 PM – 4:00 PM
Plenary Session: Hypoxic/Anoxic Injury in the CNS
  • Epigenetic Regulation of Abcc8 and Trpm4 is Associated with Intracranial Hypertension and Outcome After Severe TBI
  • Harnessing Hypoxic Adaptation to Interdict Ferroptosis and Treat Neurological Diseases
  • Hypoxia-Inducible Factors in Physiology and Medicine
  • Precision Therapy for Neonatal HI: Role of HIF and Metabolomics
  • Transcranial Magnetic Stimulation (TMS) and Post-Stroke Recovery
4:30 PM – 5:30 PM